STAT+: Pharmalittle: Two key FDA officials leaving amid Covid-19 booster debate; is Biden really ‘following the science’?

Hello, everyone, and welcome to the middle of the week. You made it this far, so why not continue, yes? Meanwhile, another busy day is unfolding here on the Pharmalot campus, where we are mulling over our calendar and plotting our next moves. No doubt, you can relate. After all, this is only the middle of the week and there is so much to be done. So time to get cracking. On that note, here are a few items of interest for you to peruse as your journey begins. Hope you have a productive day and, as always, do keep in touch. …

The two Food and Drug Administration officials in charge of leading reviews of Covid-19 vaccine applications will leave the agency this fall, STAT tells us. Marion Gruber and Phil Krause, collectively have more than 42 years of experience at the FDA and their high-profile departures sparked questions about whether it would affect FDA work during the pandemic. One reason they are leaving is disagreement with the Biden administration over the use of Covid-19 booster shots, according to The New York Times.

Continue to STAT+ to read the full story…

STAT+: Pharmalittle: Two key FDA officials leaving amid Covid-19 booster debate; is Biden really ‘following the science’?

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top